Perspective TherapeuticsCATX
美國證券 · USD
1.61
-0.65
(-28.76%)
收盤 10/24 04:00 (UTC+8)
盤後
1.66
+0.05
(+3.11%)
10/24 04:00 (UTC+8)
Perspective TherapeuticsCATX
1.61
-0.65
(-28.76%)
財務數據
損益表
- 0.00
- 0.01
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- -
- 61.85
- -29.85
- -36.59
- 46.15
- -15.20
- -27.93
- -79.43
- 76.74
- 6.58
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 81 | 76 | 43 | 209 | 290 | 342 | 234 | 369 | 526 | 325 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 81 | 76 | 43 | 209 | 290 | 342 | 234 | 369 | 526 | 325 |
營業費用 | 29,339 | 28,357 | 39,875 | 28,070 | 24,329 | - | 45,191 | - | - | 13,330 |
研發費用 | 21,544 | 21,372 | 32,924 | 20,339 | 16,620 | 14,332 | 12,883 | 12,028 | 9,275 | 7,452 |
推銷及管理費用 | 7,795 | 6,985 | 6,951 | 7,731 | 7,709 | 7,842 | 8,246 | 6,975 | 5,514 | 5,878 |
非經常性項目費用 | - | - | - | - | - | - | 24,062 | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -29,258 | -28,281 | -39,832 | -27,861 | -24,039 | -21,832 | -44,984 | -18,634 | -14,263 | -13,005 |
其他收入及費用 | 2,347 | 2,197 | 1,614 | 1,957 | 2,159 | 3,784 | 2,620 | 3,581 | 3,076 | 1,211 |
利息費用 | 71 | 105 | 64 | 65 | 119 | 128 | -73 | 69 | 23 | 29 |
稅前純益 | -26,786 | -26,189 | -37,769 | -26,483 | -21,999 | -18,177 | -43,215 | -15,122 | -12,163 | -12,284 |
所得稅 | - | - | -793 | - | - | - | -2,097 | - | - | - |
稅後純益 | -26,786 | -26,189 | -37,490 | -25,969 | -21,485 | -18,177 | -40,169 | -15,122 | -11,704 | -12,284 |
基本每股稅後盈餘(元) | -0.22 | -0.25 | -0.51 | -0.35 | -0.29 | -0.25 | -0.81 | -0.21 | -0.18 | -0.02 |
稀釋每股稅後盈餘(元) | -0.22 | -0.25 | -0.51 | -0.35 | -0.29 | -0.25 | -0.61 | -0.21 | -0.16 | -0.02 |
基本平均股數(千股) | 120651.00 | 103604.00 | 74364.00 | 74296.00 | 74235.00 | 72357.00 | 70913.00 | 70629.00 | 66648.00 | 495100.00 |
稀釋平均股數(千股) | 120651.00 | 103604.00 | 74364.00 | 74296.00 | 74235.00 | 72357.00 | 70913.00 | 70629.00 | 66648.00 | 495100.00 |
還原基本每股稅後盈餘(元) | -0.22 | -0.25 | -0.51 | -0.35 | -0.29 | -0.25 | -0.81 | -0.21 | -0.18 | -0.25 |
還原稀釋每股稅後盈餘(元) | -0.22 | -0.25 | -0.51 | -0.35 | -0.29 | -0.25 | -0.61 | -0.21 | -0.16 | -0.25 |
還原基本平均股數(千股) | 120,651 | 103,604 | 74,364 | 74,296 | 74,235 | 72,357 | 70,913 | 70,629 | 66,648 | 49,510 |
還原稀釋平均股數(千股) | 120,651 | 103,604 | 74,364 | 74,296 | 74,235 | 72,357 | 70,913 | 70,629 | 66,648 | 49,510 |
EBITDA(千元) | -26,235 | -25,448 | -37,608 | -25,687 | -21,408 | -18,307 | -42,237 | -14,384 | -11,109 | -11,899 |